These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35089390)

  • 1. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.
    Meshram RJ; Kathwate GH; Gacche RN
    Arch Virol; 2022 Mar; 167(3):717-736. PubMed ID: 35089390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis, diagnosis and management of hepatitis C.
    Boyer N; Marcellin P
    J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C.
    Sharara AI
    South Med J; 1997 Sep; 90(9):872-7. PubMed ID: 9305294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV virology and diagnosis.
    Roger S; Ducancelle A; Le Guillou-Guillemette H; Gaudy C; Lunel F
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101626. PubMed ID: 33636428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of hepatitis C virus infection in Korea.
    Suh DJ; Jeong SH
    Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus--proteins, diagnosis, treatment and new approaches for vaccine development.
    Keyvani H; Fazlalipour M; Monavari SH; Mollaie HR
    Asian Pac J Cancer Prev; 2012; 13(12):5931-49. PubMed ID: 23464383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis.
    Tada T; Toyoda H; Kumada T; Kurisu A; Sugiyama A; Akita T; Ohisa M; Aikata H; Miki D; Chayama K; Tanaka J
    J Viral Hepat; 2021 Mar; 28(3):538-547. PubMed ID: 33215790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal screening for hepatitis C - in for a penny, in for a pound.
    Garrido I; Macedo G
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):341-347. PubMed ID: 35022892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical impact of hepatitis C virus genomic variations].
    Ergünay K; Abacıoğlu H
    Mikrobiyol Bul; 2015 Oct; 49(4):625-35. PubMed ID: 26649421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
    ; ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical aspects on hepatitis C.
    Higuchi M; Tanaka E; Kiyosawa K
    Jpn J Infect Dis; 2002 Jun; 55(3):69-77. PubMed ID: 12195046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of hepatitis C virus infection and related liver disease.
    Pawlotsky JM
    Trends Microbiol; 2004 Feb; 12(2):96-102. PubMed ID: 15036326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.